Trials / Completed
CompletedNCT03601689
Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (actual)
- Sponsor
- Moroccan Society of Surgery · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Many data suggest that patients with low rectal adenocarcinoma who achieved ypT0N0 status have improved survival and disease-free survival (DFS) compared to all other stages however only few data are available regarding the specific prognosis factors of this subgroup. This retrospective multicentric study aimed to predict the prognosis of patients with complete pathological response after neoadjuvant treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | rectal resection | total mesorectal excision |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2013-12-31
- Completion
- 2016-03-31
- First posted
- 2018-07-26
- Last updated
- 2018-07-26
Locations
8 sites across 2 countries: Algeria, Morocco
Source: ClinicalTrials.gov record NCT03601689. Inclusion in this directory is not an endorsement.